Inventory, Net of HERON THERAPEUTICS, INC. /DE/ from 31 Mar 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Inventory, Net in USD history and change rate from 31 Mar 2016 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Inventory, Net for the quarter ending 31 Dec 2025 was $92,746,000, a 74% increase year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $92,746,000 +$39,586,000 +74% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $70,025,000 +$24,075,000 +52% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $72,965,000 +$30,101,000 +70% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $56,932,000 +$14,459,000 +34% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $53,160,000 +$11,050,000 +26% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $45,950,000 +$3,943,000 +9.4% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $42,864,000 -$1,759,000 -3.9% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $42,473,000 -$9,586,000 -18% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $42,110,000 -$12,463,000 -23% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $42,007,000 -$10,232,000 -20% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $44,623,000 -$16,695,000 -27% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $52,059,000 -$4,411,000 -7.8% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $54,573,000 +$6,191,000 +13% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $52,239,000 +$10,737,000 +26% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $61,318,000 +$18,518,000 +43% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $56,470,000 +$13,841,000 +32% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $48,382,000 +$6,477,000 +15% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $41,502,000 -$1,247,000 -2.9% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $42,800,000 +$1,358,000 +3.3% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $42,629,000 +$7,780,000 +22% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $41,905,000 +$16,937,000 +68% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $42,749,000 +$18,577,000 +77% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $41,442,000 +$12,172,000 +42% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $34,849,000 +$3,428,000 +11% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $24,968,000 -$14,064,000 -36% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $24,172,000 -$7,240,000 -23% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $29,270,000 +$2,073,000 +7.6% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $31,421,000 +$12,003,000 +62% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $39,032,000 +$28,924,000 +286% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $31,412,000 +$26,243,000 +508% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $27,197,000 +$22,396,000 +466% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $19,418,000 +$14,777,000 +318% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $10,108,000 +$4,768,000 +89% 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $5,169,000 +$3,186,000 +161% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 $4,801,000 +$1,489,000 +45% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $4,641,000 +$1,897,000 +69% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $5,340,000 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $1,983,000 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 $3,312,000 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 $2,744,000 31 Mar 2016 10-Q 05 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.